Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MODUS THERAPEUTICS HLDG
No Price
Closing Price XSTO 30.04.2026:
0,41 SEK
30.04.2026 10:35
Current Prices from MODUS THERAPEUTICS HLDG
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
MODTX.ST
SEK
30.04.2026 10:35
0,41 SEK
-
Share Float & Liquidity
Free Float29,11 %
Shares Float26,54 M
Shares Outstanding91,16 M
Company Profile for MODUS THERAPEUTICS HLDG Share
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
